NeuroThera Labs, a subsidiary of SciSparc Ltd., has successfully validated a proprietary quantum sampling workflow for analyzing clinical trial data. This platform uses a hybrid quantum-classical computing system from an S&P 500 company to handle complex continuous probability distributions in healthcare data. The advancement is expected to enhance analysis of large-scale clinical and biomedical datasets, supporting next-generation computational methods in life sciences. NeuroThera continues to develop this technology through its CliniQuantum initiative, aiming to improve drug development and clinical analytics.
AO, a Southern California architecture firm, earned a record 4 grand prizes and 24 merit awards at the 63rd Annual Gold Nuggets, a prestigious design competition. Their awarded projects include Bolsa Pacific, Opus, Luminary, and Independence at the P...
Pred, a peer-to-peer sports prediction exchange, has added major football leagues such as La Liga, Champions League, Europa League, and MLS to its platform alongside existing markets like the English Premier League, Formula 1, and Tennis. This expans...
State Street Global Advisors and its affiliates have increased their holdings in DCC plc to 1,100,095 ordinary shares, representing 1.2878% of the company as of July 31, 2026. The transactions included multiple purchases and a sale of shares at a pri...
The global angle seat valve market is projected to grow from $0.38 billion in 2026 to $0.53 billion by 2032, at a CAGR of 5.9%. Growth is fueled by rising industrial automation in sectors like food & beverages, pharmaceuticals, chemicals, and water t...
Bank of America reported a strong 34.4% year-over-year growth in Q2 2026 earnings per share (EPS) to $1.22, driven by record net interest income and a 33% rise in trading revenue. UBS raised its price target for the stock to $70 from $68, implying a ...
